Awardee OrganizationNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
Description
Abstract Text
The molecular basis of autoimmunity remains largely unknown. One hypothesis is that molecular abnormalities in the means by which the B cell immunoglobulin receptor is assembled or subsequently selected play a role in the tendency to develop autoantibodies. To examine this possibility, a technique has been developed to analyze the B cell receptor expressed by individual B cells without bias. Using this technique, the B cell repertoire expressed by normal individuals has been analyzed in detail. This normal data base has been employed for comparison to determine abnormalities in patients with autoimmune disease. The objective of the current study is to use single cell analysis to delineate the nature of abnormalities in the B cell immunoglobulin repertoire that might underlie autoimmune disease. The characteristics of B cells of patients with systemic lupus erythematosus (SLE) and Sjogrens's syndrome (SS) have been analyzed. The lupus repertoire shows distinct abnormalities, including evidence of enhanced mutational activity, increased receptor editing/revision and clonal expansion, consistent with intense T cell dependent stimulation. By contrast, the B cell repertoire of Sjogren's syndrome patients showed different abnormalities, including restriction of the repertoire, no enhanced mutational activity and limited receptor editing, as well as a pattern of mutations consistent with intense T cell independent stimulation. In neither disease was evidence of molecular abnormalities in receptor assembly obtained. Rather, the data are most consistent with distinct abnormalities in peripheral B cell stimulation, resulting in autoimmunity in these two autoimmune diseases. The capacity to analyze the B cell repertoire without bias has provided new insights into the nature of the abnormalities that predispose to autoimmunity. In systemic and organ-specific autoimmune diseases the B cells of interest circulate between primary and secondary lymphoid tissue and sites of inflammation. In SS, the B cells accumulating in inflamed parotid glands are polyclonal and the repertoire resembles that of the B cells in circulation. However, there is an influx or preferential homing of mutated memory B cells to the inflamed glands, which become sites of B cell proliferation and VH clonal expansion. Representative members of at least one glandular VH clone were among the circulating B cells. Circulating mutated B cells express CD27, which has become a convenient marker for identifying the memory B cell subset. In SLE patients in highly active states of disease, the number and frequency of circulating CD27 high plasma cells was greater than in SLE patients with inactive disease. The proportion of CD27+ B cells related to the duration of disease and therapeutic regiment more than the humoral levels of anti-ds DNA antibodies and circulating immune complexes, suggesting that analysis of this B cell subset may be useful to evaluate and monitor autoimmune disease activity.
Ongoing Projects:
1. Homing receptor expression on T & B cell subsets
2. B cell repertoire and mutation analysis of HED-ID, xHIM, CD40def, AID & XP
3. Peripheral & tonsillar B cell subset mutation analysis
4. Absence of memory B cells in ALPS
5. B cell repertoire and mutation analysis in post-transplantation RA
6. Repertoire & mutation analysis of human splenic B cells
7. Repertoire & mutation analysis of anergic B cells in SLE
8. Role of T-regulatory suppressor cells in SLE
9. Synergy of NIK & RAF in NFkB activation
10. B cell repertoire & mutation analysis of SpA superantigen treated macaque
11. B cell repertoire & mutation analysis of ProtL & SpA superantigen treated transgenic huIg murine model
12. B cell repertoire & mutation analysis human stem cell reconstituted SCID/NOD
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
DUNS Number
UEI
Project Start Date
Project End Date
Budget Start Date
Budget End Date
Project Funding Information for 2003
Total Funding
Direct Costs
Indirect Costs
Sub Projects
No Sub Projects information available for 1Z01AR041127-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1Z01AR041127-04
Patents
No Patents information available for 1Z01AR041127-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1Z01AR041127-04
Clinical Studies
No Clinical Studies information available for 1Z01AR041127-04
News and More
Related News Releases
No news release information available for 1Z01AR041127-04
History
No Historical information available for 1Z01AR041127-04
Similar Projects
No Similar Projects information available for 1Z01AR041127-04